Here are three things to know:
1. Patients will undergo a one- or two-level XLIF procedure with smooth PEEK, Modulus 3D-printed titanium or Cohere Porous PEEK implants.
2. The study will also generate level 1 biologic outcome evidence, as each implant group will have randomization between Osteocel Pro and cancellous allograft chips with bone marrow aspirate
3. In this two-year, follow-up study, at least 10 surgeons will assess the fusion progression in approximately 300 U.S. patients.
More articles on surface technology:
Nexxt Spine starts 1st trial of 3D-printed lumbar interbody fusion device vs. PEEK: 4 notes
Captiva Spine earns FDA clearance for 3D-printed titanium cervical cages: 3 insights
CoreLink launches expandable interbody fusion device: 3 insights
